Targeting bromodomains: epigenetic readers of lysine acetylation

P Filippakopoulos, S Knapp - Nature reviews Drug discovery, 2014 - nature.com
Lysine acetylation is a key mechanism that regulates chromatin structure; aberrant
acetylation levels have been linked to the development of several diseases. Acetyl-lysine …

The bromodomain: from epigenome reader to druggable target

R Sanchez, J Meslamani, MM Zhou - Biochimica et Biophysica Acta (BBA) …, 2014 - Elsevier
Lysine acetylation is a fundamental post-translational modification that plays an important
role in the control of gene transcription in chromatin in an ordered fashion. The …

Dual kinase-bromodomain inhibitors for rationally designed polypharmacology

P Ciceri, S Müller, A O'mahony, O Fedorov… - Nature chemical …, 2014 - nature.com
Concomitant inhibition of multiple cancer-driving kinases is an established strategy to
improve the durability of clinical responses to targeted therapies. The difficulty of discovering …

BET and HDAC inhibitors induce similar genes and biological effects and synergize to kill in Myc-induced murine lymphoma

J Bhadury, LM Nilsson… - Proceedings of the …, 2014 - National Acad Sciences
The bromodomain and extraterminal (BET) domain family of proteins binds to acetylated
lysines on histones and regulates gene transcription. Recently, BET inhibitors (BETi) have …

Acetyl-lysine binding site of bromodomain-containing protein 4 (BRD4) interacts with diverse kinase inhibitors

SWJ Ember, JY Zhu, SH Olesen, MP Martin… - ACS chemical …, 2014 - ACS Publications
Members of the bromodomain and extra terminal (BET) family of proteins are essential for
the recognition of acetylated lysine (KAc) residues in histones and have emerged as …

Bromodomain protein BRD4 is required for estrogen receptor-dependent enhancer activation and gene transcription

S Nagarajan, T Hossan, M Alawi, Z Najafova… - Cell reports, 2014 - cell.com
The estrogen receptor α (ERα) controls cell proliferation and tumorigenesis by recruiting
various cofactors to estrogen response elements (EREs) to control gene transcription. A …

Cancer epigenetics drug discovery and development: the challenge of hitting the mark

RM Campbell, PJ Tummino - The Journal of clinical …, 2014 - Am Soc Clin Investig
Over the past several years, there has been rapidly expanding evidence of epigenetic
dysregulation in cancer, in which histone and DNA modification play a critical role in tumor …

Affinity map of bromodomain protein 4 (BRD4) interactions with the histone H4 tail and the small molecule inhibitor JQ1

M Jung, M Philpott, S Müller, J Schulze… - Journal of biological …, 2014 - ASBMB
Bromodomain protein 4 (BRD4) is a member of the bromodomain and extra-terminal domain
(BET) protein family. It binds to acetylated histone tails via its tandem bromodomains BD1 …

Bromodomains and their pharmacological inhibitors

D Gallenkamp, KA Gelato, B Haendler… - …, 2014 - Wiley Online Library
Over 60 bromodomains belonging to proteins with very different functions have been
identified in humans. Several of them interact with acetylated lysine residues, leading to the …

BET bromodomain inhibitors: a patent review

JM Garnier, PP Sharp, CJ Burns - Expert opinion on therapeutic …, 2014 - Taylor & Francis
Introduction: The bromodomain (BRD) and extra-C terminal domain (BET) protein family
consists of four members (BRD2, BRD3, BRD4 and BRDT). These “epigenetic readers” bind …